ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
67 announcements
Neogen Chemicals' subsidiary, Neogen Morita New Materials Limited, approved a preferential issue of 7,20,000 equity shares worth ₹76.80 Crore to Morita Investment Limited.
CRISIL Ratings reaffirmed and revised outlooks for Neogen Chemicals and subsidiary Neogen Ionics' facilities and debt, citing improved financial risk profile and completed QIP funding.
Neogen Chemicals has paid the interest on its listed non-convertible debentures for September 2026, totaling ₹1.63 Crore.
Neogen Chemicals Ltd has submitted its quarterly shareholding pattern disclosure as per SEBI regulations. This routine filing details the current equity distribution among promoters and public shareholders.
Neogen Chemicals Limited allotted equity shares via a Qualified Institutional Placement (QIP). The allotment increases the total paid-up share capital of the company.
Neogen Chemicals is raising funds via a Qualified Institutional Placement of 26.61 lakh equity shares. This issuance is valued at approximately ₹600 Crore.
Neogen Chemicals successfully concluded its QIP, issuing 26,60,753 equity shares at an issue price of ₹2,255 per share, raising funds from qualified institutional buyers.
Neogen Chemicals Limited has opened its Qualified Institutional Placement (QIP) with a floor price of ₹2,189.73 per share, as approved by its Fund-Raising Committee.
Neogen Chemicals received a GST show-cause demand notice for ₹6.97 Crore for FY 2022-23. The company is evaluating the notice and intends to file a response.
Neogen Chemicals Ltd has fixed September 15, 2026, as the record date for the interest payment on its NCDs (ISIN: INE136S07013), payable on September 30, 2026.
Neogen Chemicals approved a Rs. 245 Crore Business Transfer Agreement between its subsidiaries, NIL and NML, to consolidate electrolyte salt manufacturing.
Neogen Chemicals reported a gift transfer of 354 equity shares between two individuals categorized as 'Other'. This off-market transaction involves no monetary consideration.
Mrs. Heena Hitesh Reshamwala (spouse of Mr. Hitesh Reshamwala) gifted 354 equity shares of Neogen Chemicals Ltd to Mr. Viren Reshamwala in an off-market transaction.
Neogen Chemicals has paid Rs.1.69 Crore in interest for its non-convertible debentures (NCDs) for August 2026. This periodic payment complies with SEBI listing regulations.
Neogen Chemicals has received shareholder approval for raising funds up to Rs. 600 Crore. The company obtained this in-principle authorization for future capital issuance.
Neogen Chemicals concluded its 37th Annual General Meeting on August 21, 2026. Proceedings included financial adoption, dividend declaration, and authorization for future fund-raising.
SBI Mutual Fund sold 2,11,931 shares of Neogen Chemicals Limited via market sale. Its stake decreased from 6.80% to 6.02%.
Neogen Chemicals has fixed August 16, 2026, as the record date for interest payments on its listed NCDs (ISIN INE136S07013).
Neogen reported robust Q1 FY27 results with 34% revenue growth and 53% EBITDA growth. Strategy pivots toward battery materials and organo-lithium, supported by a ₹600 crore QIP for de-leveraging.
Neogen Chemicals has paid Rs. 1.65 Crore as step-up interest on its listed NCDs. This filing provides the mandatory Regulation 57 interest payment intimation.
Neogen Chemicals Ltd filed its Business Responsibility and Sustainability Report (BRSR) and Assurance Report for the financial year 2025-26.
Neogen Chemicals Ltd issued the notice for its 37th Annual General Meeting scheduled for August 21, 2026. The meeting includes enabling resolutions for future capital raising.
Neogen Chemicals submitted its Integrated Annual Report for F.Y. 2025-26 and scheduled its 37th Annual General Meeting for August 21, 2026.
Neogen Chemicals confirmed the payment of interest on its non-convertible debentures. This regulatory filing satisfies standard disclosure requirements for interest payments.
Neogen reported robust Q1 FY27 results with consolidated revenue growing 34% and PAT up 67% YoY. Growth was driven by the Organolithium portfolio and the ramp-up of Neogen Ionics.
Neogen Chemicals reported Q1 FY27 results with Rs. 250 crore revenue. The Board also approved a fund-raise of up to Rs. 600 crore via QIP.
Neogen Chemicals received board approval to raise up to ₹600 Crore via issuance of equity or other eligible securities. The company will determine the specific fundraising mode later.
Neogen Chemicals Limited has recommended a final dividend of ₹0.10 per equity share for the financial year. The record date is set for 13-August-2026.
Neogen Chemicals Limited has appointed CNK & Associates LLP as its new Internal Auditor, effective July 24, 2026, for a term of 12 months.
Neogen Chemicals filed its quarterly Security Cover Certificate for NCDs as of June 30, 2026, confirming compliance with SEBI Regulations regarding debt security maintenance.